InvestorsHub Logo
Followers 655
Posts 18998
Boards Moderated 5
Alias Born 07/03/2011

Re: 02opida post# 32

Monday, 03/06/2023 8:34:59 AM

Monday, March 06, 2023 8:34:59 AM

Post# of 55
BridgeBio Announces Positive Phase 2 Cohort 5 Results of Infigratinib in Achondroplasia Demonstrating Mean Increase in Annualized Height Velocity of 3.03 cm/year with No Treatment-related Adverse Events
March 06 2023 - 07:00AM
GlobeNewswire Inc.
https://ih.advfn.com/stock-market/NASDAQ/bridgebio-pharma-BBIO/stock-news/90423204/bridgebio-announces-positive-phase-2-cohort-5-resu
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BBIO News